These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 16142363

  • 1. Expression of the inhibitors of apoptosis proteins in cisplatin-resistant prostate cancer cells.
    Nomura T, Yamasaki M, Nomura Y, Mimata H.
    Oncol Rep; 2005 Oct; 14(4):993-7. PubMed ID: 16142363
    [Abstract] [Full Text] [Related]

  • 2. Cisplatin inhibits the expression of X-linked inhibitor of apoptosis protein in human LNCaP cells.
    Nomura T, Mimata H, Yamasaki M, Nomura Y.
    Urol Oncol; 2004 Oct; 22(6):453-60. PubMed ID: 15610860
    [Abstract] [Full Text] [Related]

  • 3. [Differential gene expression of the inhibitor of apoptosis proteins in docetaxel-resistant gastric cancer cells].
    Wang TT, Wei J, Qian XP, Yu LX, Liu BR.
    Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):573-7. PubMed ID: 19102932
    [Abstract] [Full Text] [Related]

  • 4. Expression of clusterin, XIAP and survivin, and their changes by camptothecin (CPT) treatment in CPT-resistant PC-3 and CPT-sensitive LNCaP cells.
    Mizutani K, Matsumoto K, Hasegawa N, Deguchi T, Nozawa Y.
    Exp Oncol; 2006 Sep; 28(3):209-15. PubMed ID: 17080014
    [Abstract] [Full Text] [Related]

  • 5. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
    Tirrò E, Consoli ML, Massimino M, Manzella L, Frasca F, Sciacca L, Vicari L, Stassi G, Messina L, Messina A, Vigneri P.
    Cancer Res; 2006 Apr 15; 66(8):4263-72. PubMed ID: 16618750
    [Abstract] [Full Text] [Related]

  • 6. Inhibitors of apoptosis proteins in prostate cancer cell lines.
    McEleny KR, Watson RW, Coffey RN, O'Neill AJ, Fitzpatrick JM.
    Prostate; 2002 May 01; 51(2):133-40. PubMed ID: 11948968
    [Abstract] [Full Text] [Related]

  • 7. The X-linked inhibitor of apoptosis protein inhibits taxol-induced apoptosis in LNCaP cells.
    Nomura T, Mimata H, Takeuchi Y, Yamamoto H, Miyamoto E, Nomura Y.
    Urol Res; 2003 Mar 01; 31(1):37-44. PubMed ID: 12624662
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR, Abel G.
    Cancer Chemother Pharmacol; 1992 Mar 01; 30(6):444-50. PubMed ID: 1356649
    [Abstract] [Full Text] [Related]

  • 12. Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex.
    Arora V, Cheung HH, Plenchette S, Micali OC, Liston P, Korneluk RG.
    J Biol Chem; 2007 Sep 07; 282(36):26202-9. PubMed ID: 17613533
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Different docetaxel-induced apoptotic pathways are present in prostate cancer cell lines LNCaP and PC-3.
    Muenchen HJ, Poncza PJ, Pienta KJ.
    Urology; 2001 Feb 07; 57(2):366-70. PubMed ID: 11182366
    [Abstract] [Full Text] [Related]

  • 15. Elevated expression of inhibitor of apoptosis proteins in prostate cancer.
    Krajewska M, Krajewski S, Banares S, Huang X, Turner B, Bubendorf L, Kallioniemi OP, Shabaik A, Vitiello A, Peehl D, Gao GJ, Reed JC.
    Clin Cancer Res; 2003 Oct 15; 9(13):4914-25. PubMed ID: 14581366
    [Abstract] [Full Text] [Related]

  • 16. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
    Yang H, Fu JH, Hu Y, Huang WZ, Zheng B, Wang G.
    Zhonghua Yi Xue Za Zhi; 2007 Jul 17; 87(27):1934-7. PubMed ID: 17923022
    [Abstract] [Full Text] [Related]

  • 17. Characterization of cell death events induced by anti-neoplastic drugs cisplatin, paclitaxel and 5-fluorouracil on human hepatoma cell lines: Possible mechanisms of cell resistance.
    Brenes O, Arce F, Gätjens-Boniche O, Díaz C.
    Biomed Pharmacother; 2007 Jul 17; 61(6):347-55. PubMed ID: 17399942
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Human ovarian cancer and cisplatin resistance: possible role of inhibitor of apoptosis proteins.
    Li J, Feng Q, Kim JM, Schneiderman D, Liston P, Li M, Vanderhyden B, Faught W, Fung MF, Senterman M, Korneluk RG, Tsang BK.
    Endocrinology; 2001 Jan 17; 142(1):370-80. PubMed ID: 11145600
    [Abstract] [Full Text] [Related]

  • 20. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA, Helmbach H, Artuc M, Karmann D, Jurgovsky K, Schadendorf D.
    Anticancer Res; 1997 Jan 17; 17(6D):4359-70. PubMed ID: 9494534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.